Circulating progenitor cells: A comparison of patients with glioblastoma or meningioma

Acta Neurologica Belgica

Volumn 113, Issue 1, 2013, Pages 7-11

  Alexiou, George A ^a   Vartholomatos, George ^a   Karamoutsios, Achilleas ^a   Batistatou, Anna ^a   Kyritsis, Athanasios P ^a   Voulgaris, Spyridon ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Circulating progenitor cells; Glioma; Meningioma

Indexed keywords

EID: 84866355827     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0097-y     Document Type: Article

References (17)

1. Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD (2006) Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8: 79-88.
2. Wojakowski W, Kucia M, KaŸmierski M, Ratajczak MZ, Tendera M (2008) Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart 94: 27-33.
3. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
4. Rafat N, Beck GCh, Schulte J, Tuettenberg J, Vajkoczy P (2010) Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg 112: 43-49.
5. Greenfield JP, Jin DK, Young LM, Christos PJ, Abrey L, Rafii S, Gutin PH (2009) Surrogate markers predict angiogenic potential and survival in patients with glioblastoma multiforme. Neurosurgery 64: 819-826.
6. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11: 83-95.
7. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27: 1304-1305.
8. Duda DG, Cohen KS, Scadden DT, Jain RK (2007) A protocol for phenotypic detection enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2: 805-810.
9. Goon PK, Lip GY, Stonelake PS, Blann AD (2009) Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia 11: 771-779.
10. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
11. Chen MC, Yip HK, Chen CJ, Yang CH, Wu CJ, Cheng CI, Chen YH, Chai HT, Lee CP, Chang HW (2006) No age-related change in circulating endothelial progenitor cells in healthy subjects. Int Heart J 47: 95-105.
12. Bellows CF, Zhang Y, Simmons PJ, Khalsa AS, Kolonin MG (2011) Influence of BMI on level of circulating progenitor cells. Obesity (Silver Spring) 19: 1722-1726.
13. Yao Y, Kubota T, Takeuchi H, Sato K (2005) Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25: 201-206.
14. Moschovi M, Koultouki E, Stefanaki K, Sfakianos G, Tourkantoni N, Prodromou N, Alexiou GA (2011) Prognostic significance of angiogenesis in relation to Ki-67, p-53, p-27, and bcl-2 expression in embryonal tumors. Pediatr Neurosurg 47: 241-247.
15. Vredenburgh JJ, Desjardins A, Reardon DA, Peters KB, Herndon JE 2nd, Marcello J, Kirkpatrick JP, Sampson JH, Bailey L, Threatt S, Friedman AH, Bigner DD, Friedman HS (2011) The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. Clin Cancer Res 17: 4119-4124.
16. Gerstner ER, Batchelor TT (2012) Antiangiogenic therapy for glioblastoma. Cancer J 18: 45-50.
17. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, Nose T (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190.